In addition, GLIPR1 has been implicated in the regulation of epithelial–mesenchymal transition (EMT), cancer cell motility, and anti-tumor immune responses through pathways such as PI3K/PDK1/ROCK1 [51]. This evidence concerns the gene GLIPR1 and neoplasm.